本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Plus Therapeutics, Inc.

3.87
0.0000
成交量:- -
成交額:- -
市值:2,655.59萬
市盈率:-1.08
高:3.87
開:3.87
低:3.87
收:3.87
52周最高:23.43
52周最低:2.90
股本:686.20萬
流通股本:645.72萬
量比:1.39
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-3.5690
每股收益(LYR):-7.2500
淨資產收益率:-614.05%
總資產收益率:-135.36%
市淨率:4.86
市盈率(LYR):-0.53

資料載入中...

2020/08/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/04

重要事件披露

8-K - Current report
2020/06/30

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/06/17

重要事件披露

8-K - Current report
2020/06/11

重要事件披露

8-K - Current report
2020/05/26

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2020/05/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/05/14

重要事件披露

8-K - Current report
2020/05/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/05/11

重要事件披露

8-K - Current report
2020/04/29

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/04/23

重要事件披露

Current report, items 1.01, 3.03, and 9.01
2020/03/30

重要事件披露

8-K - Current report
2020/03/30

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/30

重要事件披露

Current report, items 1.01, 3.02, 7.01, and 9.01
2020/03/12

重要事件披露

Current report, items 5.02, 8.01, and 9.01
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/11

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超過5%披露

Statement of acquisition of beneficial ownership by individuals